Allgens Ebitda from 2010 to 2024
| 688613 Stock | 19.68 0.14 0.72% |
EBITDA | First Reported 2010-12-31 | Previous Quarter 122.8 M | Current Value 92.8 M | Quarterly Volatility 39.8 M |
Check Allgens Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Allgens Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 12.6 M, Interest Expense of 1.7 M or Selling General Administrative of 92.6 M, as well as many indicators such as . Allgens financial statements analysis is a perfect complement when working with Allgens Medical Valuation or Volatility modules.
Allgens | Ebitda |
Currently Active Assets on Macroaxis
Other Information on Investing in Allgens Stock
Allgens Medical financial ratios help investors to determine whether Allgens Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Allgens with respect to the benefits of owning Allgens Medical security.